Cardinal Health, Inc. $CAH Shares Sold by Achmea Investment Management B.V.

Achmea Investment Management B.V. lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 0.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 194,960 shares of the company’s stock after selling 1,124 shares during the quarter. Achmea Investment Management B.V. owned about 0.08% of Cardinal Health worth $32,753,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the business. MassMutual Private Wealth & Trust FSB raised its holdings in Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after purchasing an additional 62 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in shares of Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after buying an additional 69 shares in the last quarter. Perigon Wealth Management LLC boosted its position in shares of Cardinal Health by 3.2% in the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after buying an additional 72 shares in the last quarter. Community Bank & Trust Waco Texas lifted its holdings in Cardinal Health by 1.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after purchasing an additional 74 shares in the last quarter. Finally, Atlantic Edge Private Wealth Management LLC lifted its holdings in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after purchasing an additional 75 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Activity at Cardinal Health

In related news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 in the last three months. 0.12% of the stock is owned by company insiders.

Cardinal Health Trading Up 0.8%

NYSE:CAH opened at $196.84 on Thursday. Cardinal Health, Inc. has a 1-year low of $113.65 and a 1-year high of $200.14. The business’s 50-day moving average price is $157.95 and its two-hundred day moving average price is $155.76. The firm has a market capitalization of $46.77 billion, a price-to-earnings ratio of 30.52, a PEG ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. TD Cowen increased their price objective on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research report on Monday. Jefferies Financial Group set a $220.00 price target on shares of Cardinal Health and gave the stock a “buy” rating in a research report on Monday. Leerink Partners boosted their price target on Cardinal Health from $187.00 to $211.00 in a research note on Friday, October 31st. Citigroup boosted their target price on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a report on Friday, October 31st. Finally, UBS Group boosted their price objective on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Eleven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $203.31.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.